Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix
Condition(s):Keloid; Scleroderma, Localized; Acne Keloidalis; Scars; Granuloma AnnulareLast Updated:May 1, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Keloid; Scleroderma, Localized; Acne Keloidalis; Scars; Granuloma AnnulareLast Updated:May 1, 2015Completed
Condition(s):Juvenile Idiopathic Arthritis; Systemic Lupus Erythematosus; Mixed Connective Tissue Disease; Juvenile Ankylosing Spondylitis; Juvenile Dermatomyositis; Localized Scleroderma; Systemic Sclerosis; Vasculitis; Sarcoid; Fibromyalgia, Primary; Auto-inflammatory Disease; Idiopathic Uveitis IdiopathicLast Updated:November 17, 2015Completed
Condition(s):SclerodermaLast Updated:February 28, 2024Not yet recruiting
Condition(s):Scleroderma, SystemicLast Updated:May 6, 2022Completed
Condition(s):Systemic SclerodermaLast Updated:February 14, 2023Recruiting
Condition(s):Scleroderma, DiffuseLast Updated:September 28, 2022Not yet recruiting
Condition(s):SclerodermaLast Updated:November 30, 2023Completed
Condition(s):Scleroderma, SystemicLast Updated:March 15, 2022Unknown status
Condition(s):SclerodermaLast Updated:December 5, 2023Enrolling by invitation
Condition(s):SclerodermaLast Updated:January 11, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.